After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law LOS ANGELES, ...
The US Food and Drug Administration has missed its latest deadline to propose banning formaldehyde and certain formaldehyde-releasing chemicals from hair-straightening products, often used by Black ...
Medicare program’s existing statutory framework and reimbursement policies long-predate digital health technologies, ...
46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...
The FDA has fast-tracked six therapies since December 2025 through its priority review and National Priority Voucher programs, including the first approval issued under the agency’s new pilot pathway.
A popular weight loss product has been recalled nationwide after hair was reportedly found in a pre-filled syringe, according ...
Passional Boutique & Sexploratorium displays mannequins in leather handcuffs, vibrators, and posters of women in lingerie in ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
The company said the regulator accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year old.
The drug is the first GLP-1 oral weight-loss drug for adults, though Eli Lilly expects approval for a version of Zepbound this year ...
The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.
Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback